Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 14/20 | 0.40 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13254135 | 0.92 | KIF11 (0.41) | KIF11KCNN4KCNH2MAPTTDP1 | |
| SCHEMBL15761354 | 0.91 | KIF11 (0.39) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL25835596 | 0.91 | KIF11 (0.36) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL25835595 | 0.90 | KIF11 (0.35) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL15505320 | 0.89 | HTR2A (0.35) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL15508928 | 0.89 | NPC1 (0.37) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL17751726 | 0.88 | KMT2A (0.38) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL25657469 | 0.87 | KCNH2 (0.40) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL23559817 | 0.86 | KIF11 (0.33) | KIF11KCNN4HTR2AHTR2CADRA1A | |
| SCHEMBL13254134 | 0.86 | CES2 (0.36) | KIF11KCNH2L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374045-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. | 2023-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230374045-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | IAPP, GPR119, INSR | KIF11 4199/4885KCNN4 3469/4885HTR2A 3402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.